{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:08:36Z","timestamp":1781222916139,"version":"3.54.1"},"reference-count":150,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cad. Sa\u00fade P\u00fablica"],"published-print":{"date-parts":[[2006,4]]},"abstract":"<jats:p>Injection drug users (IDUs) continue to comprise a major risk group for HIV infection throughout the world and represent the focal population for HIV epidemics in Asia and Eastern Europe\/Russia. HIV prevention programs have ranged from HIV testing and counseling, education, behavioral and network interventions, drug abuse treatment, bleach disinfection of needles, needle exchange and expanded syringe access, as well as reducing transition to injection and primary substance abuse prevention. With the advent of highly active antiretroviral therapy (HAART) in 1996, dramatic clinical improvements have been seen. In addition, the treatment's impact on reducing HIV viral load (and therefore transmission by all routes) provides a stronger rationale for an expansion of the focus on prevention to emphasize early identification and treatment of HIV infected individuals. However, treatment of IDUs has many challenges including adherence, resistance and relapse to high risk behaviors, all of which impact issues of access and ultimately effectiveness of potent antiretroviral treatment. A major current challenge in addressing the HIV epidemic revolves around an appropriate approach to HIV treatment for IDUs.<\/jats:p>","DOI":"10.1590\/s0102-311x2006000400002","type":"journal-article","created":{"date-parts":[[2006,4,17]],"date-time":"2006-04-17T18:50:40Z","timestamp":1145299840000},"page":"705-718","source":"Crossref","is-referenced-by-count":31,"title":["Access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death"],"prefix":"10.1590","volume":"22","author":[{"given":"David","family":"Vlahov","sequence":"first","affiliation":[{"name":"New York Academy of Medicine,  U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Celentano","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health,  U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Drug injecting and HIV infection: global dimensions and local responses","author":"Stimson G","year":"1998"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1081\/JA-120028488","article-title":"Sharing of noninjection drug-use implements as a risk factor for hepatitis C","volume":"39","author":"Tortu S","year":"2004","journal-title":"Subst Use Misuse","ISSN":"https:\/\/id.crossref.org\/issn\/1082-6084","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0193-953X(03)00110-2","article-title":"Cognitive impairment in substance abuse","volume":"27","author":"Vik PW","year":"2004","journal-title":"Psychiatr Clin North Am","ISSN":"https:\/\/id.crossref.org\/issn\/0193-953X","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4615-2980-4_26","article-title":"Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection","volume":"335","author":"Peterson PK","year":"1993","journal-title":"Adv Exp Med Biol","ISSN":"https:\/\/id.crossref.org\/issn\/0065-2598","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00042560-199903010-00010","article-title":"Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States","volume":"20","author":"Pezzotti P","year":"1999","journal-title":"Italian Seroconversion Study. J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-5728(97)00230-0","article-title":"In vivo effects of cocaine on immune cell function","volume":"83","author":"Pellegrino T","year":"1998","journal-title":"J Neuroimmunol","ISSN":"https:\/\/id.crossref.org\/issn\/0165-5728","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/00002030-200411190-00010","article-title":"Global overview of injecting drug use and HIV infection among injecting drug users","volume":"18","author":"Aceijas C","year":"2004","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref8","first-page":"889","article-title":"Illicit intravenous drug use in Johannesburg  medical complications and prevalence of HIV infection","volume":"87","author":"Williams PG","year":"1997","journal-title":"S Afr Med J","ISSN":"https:\/\/id.crossref.org\/issn\/0038-2469","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0140-6736(05)70276-2","article-title":"Alcohol and public health","volume":"365","author":"Room R","year":"2005","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"issue":"4 Suppl 3","key":"ref10","first-page":"iii59","article-title":"HIV prevention among injection drug users: the need for integrated models","volume":"80","author":"Metzger DS","year":"2003","journal-title":"J Urban Health","ISSN":"https:\/\/id.crossref.org\/issn\/1099-3460","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1360-0443.2004.00963.x","article-title":"Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users","volume":"100","author":"Sullivan LE","year":"2005","journal-title":"Addiction","ISSN":"https:\/\/id.crossref.org\/issn\/0965-2140","issn-type":"print"},{"key":"ref12","first-page":"1049","article-title":"Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up","volume":"6","author":"Metzger DS","year":"1993","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.2196\/jmir.6.4.e41","article-title":"Crystal methamphetamine use predicts incident STD infection among men who have sex with men recruited online: a nested case-control study","volume":"6","author":"Hirshfield S","year":"2004","journal-title":"J Med Internet Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1300\/J082v41n02_02","article-title":"A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men","volume":"41","author":"Halkitis PN","year":"2001","journal-title":"J Homosex","ISSN":"https:\/\/id.crossref.org\/issn\/0091-8369","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/A:1024095016181","article-title":"Barebacking among gay and bisexual men in New York City: explanations for the emergence of intentional unsafe behavior","volume":"32","author":"Halkitis PN","year":"2003","journal-title":"Arch Sex Behav","ISSN":"https:\/\/id.crossref.org\/issn\/0004-0002","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1300\/J069v21n01_08","article-title":"Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles","volume":"21","author":"Shoptaw S","year":"2002","journal-title":"J Addict Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1055-0887","issn-type":"print"},{"issue":"1 Suppl 1","key":"ref17","doi-asserted-by":"crossref","first-page":"i62","DOI":"10.1093\/jurban\/jti025","article-title":"Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men","volume":"82","author":"Colfax G","year":"2005","journal-title":"J Urban Health","ISSN":"https:\/\/id.crossref.org\/issn\/1099-3460","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/B:AIBE.0000004727.23306.20","article-title":"Why HIV infections have increased among men who have sex with men and what to do about it: findings from California focus groups","volume":"7","author":"Morin SF","year":"2003","journal-title":"AIDS Behav","ISSN":"https:\/\/id.crossref.org\/issn\/1090-7165","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.OLQ.0000086603.55760.54","article-title":"Risk factors for rectal gonococcal infection amidst resurgence in HIV transmission","volume":"30","author":"Kim AA","year":"2003","journal-title":"Sex Transm Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0148-5717","issn-type":"print"},{"key":"ref20","first-page":"119","article-title":"Circuit party attendance, club drug use, and unsafe sex in gay men","volume":"13","author":"Mattison AM","year":"2001","journal-title":"J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.drugalcdep.2004.05.003","article-title":"A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men","volume":"76","author":"Semple SJ","year":"2004","journal-title":"Drug Alcohol Depend","ISSN":"https:\/\/id.crossref.org\/issn\/0376-8716","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/095646240401501012","article-title":"Methamphetamine users in northern Thailand: changing demographics and risks for HIV and STD among treatment-seeking substance abusers","volume":"15","author":"Beyrer C","year":"2004","journal-title":"Int J STD AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0956-4624","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/sti.2004.013094","article-title":"Seroprevalence of and risk factors for HIV-1 infection among South American men who have sex with men","volume":"80","author":"Bautista CT","year":"2004","journal-title":"Sex Transm Infect","ISSN":"https:\/\/id.crossref.org\/issn\/1368-4973","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1300\/J069v17n04_03","article-title":"Stimulant abuse treatment as HIV prevention","volume":"17","author":"Shoptaw S","year":"1998","journal-title":"J Addict Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1055-0887","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/B:AIBE.0000017528.39338.75","article-title":"Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment","volume":"8","author":"Reback CJ","year":"2004","journal-title":"AIDS Behav","ISSN":"https:\/\/id.crossref.org\/issn\/1090-7165","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/02791072.2001.10400476","article-title":"\"Have a piss, drink ogogoro, smoke igbo, but don't take gbana\" hard and soft drugs in Nigeria: a critical comparison of official policies and the view on the street","volume":"33","author":"Klein A","year":"2001","journal-title":"J Psychoactive Drugs","ISSN":"https:\/\/id.crossref.org\/issn\/0279-1072","issn-type":"print"},{"key":"ref27","first-page":"301","article-title":"Prevalence of substance use among students in a Kenyan University: a preliminary report","volume":"76","author":"Odek-Ogunde M","year":"1999","journal-title":"East Afr Med J","ISSN":"https:\/\/id.crossref.org\/issn\/0012-835X","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(97)00067-7","article-title":"Psychoactive substance abuse among inmates of a Nigerian prison population","volume":"47","author":"Adesanya A","year":"1997","journal-title":"Drug Alcohol Depend","ISSN":"https:\/\/id.crossref.org\/issn\/0376-8716","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/00002030-199411000-00001","article-title":"How effective are risk-reduction interventions targeting injecting drug users?","volume":"8","author":"Booth RE","year":"1994","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00002030-199808000-00015","article-title":"Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users","volume":"12","author":"Gibson DR","year":"1998","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref31","series-title":"Preventing AIDS: theories and methods of behavioral interventions. AIDS revention and mental health","first-page":"5","volume-title":"Social cognitive theory and exercise of control over HIV infection","author":"Bandura A","year":"1994"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02512026","article-title":"The long term outcome of a personal network-oriented HIV prevention intervention for injecting drug users: the SAFE Study","volume":"24","author":"Latkin C","year":"1996","journal-title":"Am J Community Psychol","ISSN":"https:\/\/id.crossref.org\/issn\/0091-0562","issn-type":"print"},{"key":"ref33","first-page":"144","article-title":"Network models for HIV outreach and prevention programs for drug users","volume":"151","author":"Trotter II RT","year":"1995","journal-title":"NIDA Res Monogr","ISSN":"https:\/\/id.crossref.org\/issn\/1046-9516","issn-type":"print"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1176\/ps.48.10.1283","article-title":"Reduction in risk behavior among adults with severe mental illness who learned to advocate for HIV prevention","volume":"48","author":"Kelly JA","year":"1997","journal-title":"Psychiatr Serv","ISSN":"https:\/\/id.crossref.org\/issn\/1075-2730","issn-type":"print"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/09540120410001640986","article-title":"Popular opinion leaders and HIV prevention peer education: resolving discrepant findings, and implications for the development of effective community programmes","volume":"16","author":"Kelly JA","year":"1997","journal-title":"AIDS Care","ISSN":"https:\/\/id.crossref.org\/issn\/0954-0121","issn-type":"print"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1081\/JA-120030059","article-title":"Survival of human immunodeficiency virus type 1 after rinsing injection syringes with different cleaning solutions","volume":"39","author":"Abdala N","year":"2004","journal-title":"Subst Use Misuse","ISSN":"https:\/\/id.crossref.org\/issn\/1082-6084","issn-type":"print"},{"key":"ref37","first-page":"754","article-title":"Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach","volume":"7","author":"Shapshak P","year":"1994","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref38","first-page":"760","article-title":"Field effectiveness of needle disinfection among injecting drug users","volume":"7","author":"Vlahov D","year":"1994","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref39","first-page":"700","article-title":"Bleach use and HIV seroconversion among New York City injection drug users","volume":"7","author":"Titus S","year":"1994","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00002030-199402000-00010","article-title":"HIV seroconversion in intravenous drug users in San Francisco, 1985-1990","volume":"8","author":"Moss AR","year":"1994","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref41","first-page":"S85","article-title":"Interventions to prevent HIV risk behaviors","volume":"14 Suppl 2","author":"National Institutes","year":"2000","journal-title":"National Institutes of Health Consensus Development Conference Statement February 11-13, 1997. AIDS"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/00002030-200006001-00006","article-title":"Structural interventions to reduce HIV transmission among injecting drug users","volume":"14 Suppl 1","author":"Des Jarlais","year":"2000","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2105\/AJPH.89.3.299","article-title":"Community-level interventions are needed to prevent new HIV infection","volume":"89","author":"Kelly JA","year":"2000","journal-title":"Am J Public Health","ISSN":"https:\/\/id.crossref.org\/issn\/0090-0036","issn-type":"print"},{"key":"ref44","first-page":"41","article-title":"Developing community networks to deliver HIV prevention interventions","volume":"111 Suppl 1","author":"Guenther-Grey C","year":"1996","journal-title":"Public Health Rep","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3549","issn-type":"print"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/109019818601300411","article-title":"AIDS risk reduction: a community health education intervention for minority high risk group members","volume":"13","author":"Williams LS","year":"1996","journal-title":"Health Educ Q","ISSN":"https:\/\/id.crossref.org\/issn\/0195-8402","issn-type":"print"},{"key":"ref46","first-page":"326","article-title":"A community-based acquired immunodeficiency syndrome education intervention study in Kunshan county","volume":"22","author":"Sun X","year":"2001","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"ref47","first-page":"49","article-title":"Toward reducing the spread of HIV in northeastern Thai villages: evaluation of a village-based intervention","volume":"9","author":"Elkins D","year":"1997","journal-title":"AIDS Educ Prev","ISSN":"https:\/\/id.crossref.org\/issn\/0899-9546","issn-type":"print"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3109\/10826089909039429","article-title":"Community-based intervention to reduce demand for drugs in Northern Thai tribal villages","volume":"34","author":"Barrett ME","year":"1999","journal-title":"Subst Use Misuse","ISSN":"https:\/\/id.crossref.org\/issn\/1082-6084","issn-type":"print"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00003727-200501000-00005","article-title":"The community health advisor program and the deep South network for cancer control: health promotion programs for volunteer community health advisors","volume":"28","author":"Hinton A","year":"2005","journal-title":"Fam Community Health","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6379","issn-type":"print"},{"key":"ref50","first-page":"806","article-title":"Training pharmacy workers in recognition, management, and prevention of STDs: district-randomized controlled trial","volume":"81","author":"Garcia P","year":"2003","journal-title":"Bull World Health Organ","ISSN":"https:\/\/id.crossref.org\/issn\/0042-9686","issn-type":"print"},{"key":"ref51","first-page":"671","article-title":"The effect of neighborhood-based community organizing: results from the Seattle Minority Youth Health Project","volume":"36","author":"Cheadle A","year":"2001","journal-title":"Health Serv Res","ISSN":"https:\/\/id.crossref.org\/issn\/0017-9124","issn-type":"print"},{"key":"ref52","first-page":"561","article-title":"The Kaiser Family Foundation Community Health Promotion Grants Program: findings from an outcome evaluation","volume":"35","author":"Wagner EH","year":"2000","journal-title":"Health Serv Res","ISSN":"https:\/\/id.crossref.org\/issn\/0017-9124","issn-type":"print"},{"issue":"5 Pt 1","key":"ref53","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1006\/pmed.1998.0348","article-title":"Correlates of the sustainability of community-based heart health promotion interventions","volume":"27","author":"O'Loughlin J","year":"1998","journal-title":"Prev Med","ISSN":"https:\/\/id.crossref.org\/issn\/0091-7435","issn-type":"print"},{"issue":"3 Suppl 1","key":"ref54","first-page":"S108","article-title":"Eliminating disparities in HIV disease: community mobilization to prevent HIV transmission among Black and Hispanic young adults in Broward County, Florida","volume":"14","author":"Darrow WW","year":"2004","journal-title":"Ethn Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1049-510X","issn-type":"print"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1001\/jama.1989.03420220073030","article-title":"A multicommunity trial for primary prevention of adolescent drug abuse: Effects on drug use prevalence","volume":"261","author":"Pentz MA","year":"1989","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2105\/AJPH.92.12.1952","article-title":"Community-based trial to prevent drug use among youths in Yunnan, China","volume":"92","author":"Wu Z","year":"2002","journal-title":"Am J Public Health","ISSN":"https:\/\/id.crossref.org\/issn\/0090-0036","issn-type":"print"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00042560-199509000-00012","article-title":"Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers  Connecticut, 1992-1993","volume":"10","author":"Groseclose SL","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1077-9450","issn-type":"print"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1097\/00042560-199802001-00014","article-title":"Injection and syringe sharing among HIV-infected injection drug users: implications for prevention of HIV transmission. Supplement to HIV\/AIDS Surveillance Group","volume":"18 Suppl 1","author":"Diaz T","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1077-9450","issn-type":"print"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/sti.2003.008912","article-title":"A rapid assessment of community-wide HIV\/STI intervention in China","volume":"81","author":"Wang DB","year":"2005","journal-title":"Sex Transm Infect","ISSN":"https:\/\/id.crossref.org\/issn\/1368-4973","issn-type":"print"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/088922203769232511","article-title":"HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay","volume":"19","author":"Hu DJ","year":"2003","journal-title":"AIDS Res Hum Retroviruses","ISSN":"https:\/\/id.crossref.org\/issn\/0889-2229","issn-type":"print"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archinte.161.10.1281","article-title":"Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective","volume":"161","author":"Strathdee SA","year":"2001","journal-title":"Arch Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00042560-199805010-00010","article-title":"Long-term trends in self-reported HIV risk behavior: injection drug users in Los Angeles, 1987 through 1995","volume":"18","author":"Longshore D","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1077-9450","issn-type":"print"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2105\/AJPH.92.3.382","article-title":"Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999","volume":"92","author":"Maslow CB","year":"2002","journal-title":"Am J Public Health","ISSN":"https:\/\/id.crossref.org\/issn\/0090-0036","issn-type":"print"},{"key":"ref64","series-title":"Report on street children and drug abuse: social and health consequences","author":"National Institute","year":"2000"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less AIDS Clinical Trials Group 320 Study Team","volume":"337","author":"Hammer SM","year":"1997","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.280.17.1497","article-title":"Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration Multicenter AIDS Cohort Study Investigators","volume":"280","author":"Detels R","year":"1998","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0140-6736(00)02069-9","article-title":"Survival after introduction of HAART in people with known duration of HIV-1 infection","volume":"355","year":"2000","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"Murphy EL","year":"2001","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/archinte.162.17.1973","article-title":"Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease","volume":"162","author":"Anastos K","year":"2002","journal-title":"Arch Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1001\/jama.286.20.2568","article-title":"Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy","volume":"286","author":"Hogg RS","year":"2001","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies","volume":"360","author":"Egger M","year":"2002","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00042560-199501000-00011","article-title":"Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men","volume":"8","author":"Galai N","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1077-9450","issn-type":"print"},{"key":"ref73","first-page":"93","article-title":"Declino dei linfociti CD4+ dopo la sieroconversione: uno studio longitudinale su 941 soggetti","volume":"5","author":"Pezzotti P","year":"1994","journal-title":"Giornale Italiano dell'AIDS"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00042560-199903010-00010","article-title":"Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study","volume":"20","author":"Pezzotti P","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1077-9450","issn-type":"print"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1097\/00002030-199912240-00008","article-title":"Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study","volume":"13","author":"Junghans C","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00126334-199912010-00008","article-title":"A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival","volume":"22","author":"Mocroft A","year":"1999","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/aje\/kwi133","article-title":"Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection","volume":"161","author":"Vlahov D","year":"2005","journal-title":"Am J Epidemiol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9262","issn-type":"print"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1086\/422848","article-title":"Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy","volume":"190","author":"Wang C","year":"2004","journal-title":"J Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00126334-200107010-00006","article-title":"Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection","volume":"27","author":"Lucas GM","year":"2004","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00002030-200106150-00006","article-title":"Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy","volume":"15","author":"Poundstone KE","year":"2001","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/00002030-200109070-00015","article-title":"Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users","volume":"15","author":"Celentano DD","year":"2001","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref82","first-page":"656","article-title":"Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users","volume":"169","author":"Wood E","year":"2003","journal-title":"CMAJ","ISSN":"https:\/\/id.crossref.org\/issn\/0820-3946","issn-type":"print"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1001\/jama.1997.03540480062040","article-title":"Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society- USA panel","volume":"277","author":"Carpenter CCJ","year":"1997","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jama.280.6.547","article-title":"Barriers to use of free antiretroviral therapy in injection drug users","volume":"280","author":"Strathdee SA","year":"1998","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jama.280.6.544","article-title":"Self-reported antiretroviral therapy in injection drug users","volume":"280","author":"Celentano DD","year":"1999","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.281.24.2305","article-title":"Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study","volume":"281","author":"Shapiro MF","year":"1999","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJM199812243392606","article-title":"The care of HIV-infected adults in the United States","volume":"339","author":"Bozette SA","year":"1998","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00002030-199704000-00009","article-title":"Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups","volume":"11","author":"Dorucci M","year":"1997","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02599388","article-title":"Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons","volume":"6","author":"Stein MD","year":"1997","journal-title":"J Gen Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0884-8734","issn-type":"print"},{"key":"ref90","first-page":"392","article-title":"National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups","volume":"4","author":"Roseberg PS","year":"1991","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1077-9450","issn-type":"print"},{"key":"ref91","first-page":"99","article-title":"Delivering HIV services to vulnerable populations: a review of CARE Act-funded research","volume":"117","author":"McKinney MM","year":"2002","journal-title":"Public Health Rep","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3549","issn-type":"print"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2105\/AJPH.81.10.1285","article-title":"Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus","volume":"81","author":"Solomon L","year":"1991","journal-title":"Am J Public Health","ISSN":"https:\/\/id.crossref.org\/issn\/0090-0036","issn-type":"print"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1089\/apc.1996.10.240","article-title":"A model for the delivery of care for HIV-positive clients","volume":"10","author":"Dykeman MC","year":"1996","journal-title":"AIDS Patient Care STDS","ISSN":"https:\/\/id.crossref.org\/issn\/1087-2914","issn-type":"print"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/515081","article-title":"Clinical experience and choice of drug therapy for human immunodeficiency virus disease","volume":"28","author":"Brosgart CL","year":"1996","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/jama.1995.03530170060033","article-title":"Ability of primary care physicians to recognize physical findings associated with HIV infection","volume":"274","author":"Paauw DS","year":"1995","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.1997.03550010077044","article-title":"Protease inhibitors in the homeless","volume":"278","author":"Bangsberg D","year":"1997","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1086\/516487","article-title":"The Sydney Primary HIV Infection Study Group: Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine","volume":"175","author":"Imrie A","year":"1997","journal-title":"J Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM199807303390504","article-title":"Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors","volume":"339","author":"Hecht FM","year":"1998","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jama.283.10.1329","article-title":"Strategies for long-term success in the treatment of HIV infection","volume":"283","author":"Gallant JE","year":"2000","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.1997.03550010077044","article-title":"Protease inhibitors in the homeless","volume":"278","author":"Bangsberg D","year":"1997","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"504","DOI":"10.7326\/0003-4819-129-6-199809150-00015","article-title":"The era of adherence to HIV therapy","volume":"129","author":"Altice FL","year":"1998","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref102","first-page":"1","article-title":"Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents","volume":"47","year":"1998","journal-title":"MMWR Recomm Rep"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","article-title":"Adherence to protease inhibitor therapy and outcomes in patients with HIV infection","volume":"136","author":"Paterson DL","year":"2000","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/jama.279.24.1977","article-title":"Public health implication of antiretroviral therapy and HIV drug resistance","volume":"279","author":"Wainberg MA","year":"1998","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref105","first-page":"S61","article-title":"Attaining higher goals in HIV treatment: the central importance of adherence","volume":"13 Suppl 1","author":"Friedland GH","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1525-1497.2002.11214.x","article-title":"A prospective study of predictors of adherence to combination antiretroviral medication","volume":"17","author":"Golin CE","year":"2002","journal-title":"J Gen Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0884-8734","issn-type":"print"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/00002030-199906180-00014","article-title":"The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response","volume":"13","author":"Haubrich RH","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00126334-200004150-00005","article-title":"Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens","volume":"23","author":"Gifford AL","year":"2000","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00126334-200107010-00006","article-title":"Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection","volume":"27","author":"Lucas GM","year":"2001","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1086\/520443","article-title":"Adherence of HIV-infected patients to antiretroviral therapy","volume":"29","author":"Singh N","year":"1999","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref111","author":"Lin MK","year":"2002"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11606-002-0044-3","article-title":"Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users","volume":"17","author":"Arnsten JH","year":"2002","journal-title":"J Gen Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0884-8734","issn-type":"print"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(00)80010-1","article-title":"Drug abuse, methadone treatment, and health services use among injection drug users with AIDS","volume":"60","author":"Sambamoorthi U","year":"2000","journal-title":"Drug Alcohol Depend","ISSN":"https:\/\/id.crossref.org\/issn\/0376-8716","issn-type":"print"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/340197","article-title":"Adherence to antiretroviral therapy by Human Immunodeficiency Virus-infected patients","author":"Turner BJ","year":"2002","journal-title":"J Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/clinids\/10.2.377","article-title":"Role of drug abuse treatment in limiting the spread of AIDS","volume":"10","author":"Hubbard RL","year":"1988","journal-title":"Rev Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0162-0886","issn-type":"print"},{"key":"ref116","first-page":"1049","article-title":"HIV seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up","volume":"6","author":"Metzger DS","year":"1993","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref117","series-title":"The effectiveness of methadone maintenance treatment","author":"Ball JC","year":"1991"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0376-8716(99)00104-0","article-title":"Substance abuse treatment as an HIV prevention strategy: a review","volume":"59","author":"Sorensen J","year":"2000","journal-title":"Drug Alcohol Depend","ISSN":"https:\/\/id.crossref.org\/issn\/0376-8716","issn-type":"print"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/108729103771928708","article-title":"Theory-guided, empirically supported avenues for intervention on HIV medication non-adherence: findings from the Health Living Project","volume":"17","author":"Johnson MO","year":"2003","journal-title":"AIDS Patient Care STDS","ISSN":"https:\/\/id.crossref.org\/issn\/1087-2914","issn-type":"print"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00126334-200101010-00012","article-title":"Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Conhort Study","volume":"26","author":"Kleeberger CA","year":"2001","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11908-999-0049-8","article-title":"Medication adherence among HIV-infected patients: understanding the complex behavior of patients taking this complex therapy","volume":"1","author":"Cheever LW","year":"2001","journal-title":"Curr Infect Dis Rep"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0738-3991(01)00219-1","article-title":"Patient adherence to HIV medication regimens: a review of published and abstract reports","volume":"46","author":"Fogarty L","year":"2002","journal-title":"Patient Educ Couns","ISSN":"https:\/\/id.crossref.org\/issn\/0738-3991","issn-type":"print"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00126334-200202011-00002","article-title":"Addressing the challenges of adherence","volume":"29","author":"Bartlett JA","year":"2002","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2105\/AJPH.92.3.388","article-title":"Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco","volume":"92","author":"Katz MH","year":"2002","journal-title":"Am J Public Health","ISSN":"https:\/\/id.crossref.org\/issn\/0090-0036","issn-type":"print"},{"key":"ref125","first-page":"45","article-title":"Increases in unsafe sex and rectal gonorrhea among men who have sex with men  San Francisco, California, 1994-1997","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep","ISSN":"https:\/\/id.crossref.org\/issn\/0149-2195","issn-type":"print"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00002030-200102160-00010","article-title":"Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection","volume":"15","author":"Dukers NH","year":"2001","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00042560-200111010-00017","article-title":"Viral load, perceived infectivity, and unprotected intercourse","volume":"28","author":"Kalichman SC","year":"2001","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"F91","DOI":"10.1097\/00002030-199810000-00001","article-title":"Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex","volume":"12","author":"Kelly JA","year":"1998","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/eurpub\/11.3.251","article-title":"Highly active antiretroviral therapy (HAART). Awareness and beliefs about infectivity and the influence on sexual behaviour in the general population of Sweden","volume":"11","author":"Herlitz CA","year":"2001","journal-title":"Eur J Public Health"},{"key":"ref130","first-page":"F33","article-title":"Sexual behavior changes and protease inhibitor therapy","volume":"14","author":"Miller M","year":"2000","journal-title":"SEROCO Study Group. AIDS"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00002030-200203290-00013","article-title":"Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men","volume":"16","author":"Ostrow DG","year":"2002","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00007611-200204000-00009","article-title":"Protease inhibitor combination therapy and decreased condom use among gay men","volume":"95","author":"DiClemente RJ","year":"2002","journal-title":"South Med J","ISSN":"https:\/\/id.crossref.org\/issn\/0038-4348","issn-type":"print"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/jech.56.5.349","article-title":"Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users","volume":"56","author":"Bouhnik AD","year":"2002","journal-title":"J Epidemiol Community Health","ISSN":"https:\/\/id.crossref.org\/issn\/0141-7681","issn-type":"print"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1097\/00002030-200111230-00013","article-title":"Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users","volume":"15","author":"Vlahov D","year":"2001","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/383033","article-title":"Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users","volume":"38","author":"Tun W","year":"2004","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/00002030-200309050-00014","article-title":"Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users","volume":"17","author":"Tun W","year":"2004","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jama.292.2.224","article-title":"Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review","volume":"292","author":"Crepaz N","year":"2004","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMoa013552","article-title":"Antiretroviral-drug resistance among patients recently infected with HIV","volume":"347","author":"Little SJ","year":"2002","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(05)74227-6","article-title":"Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report","volume":"365","author":"Markowitz M","year":"2005","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/00002030-199905280-00015","article-title":"Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users","volume":"13","author":"Alexander CS","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/jama.282.12.1135","article-title":"HIV-1 drug resistance in newly infected individuals","volume":"282","author":"Boden D","year":"1999","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/jama.282.12.1142","article-title":"Reduced antiretroviral drug susceptibility among patients with primary HIV infection","volume":"282","author":"Little SJ","year":"1999","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1097\/00002030-200001280-00003","article-title":"Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use: Investigators of the Quebec Primary Infection Study","volume":"14","author":"Salomon H","year":"2000","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/315686","article-title":"Prevalence of mutations associated with reduced antiretroviral drug susceptibility among Human Immunodeficiency Virus type 1 seroconverters in the United States, 1993-1998","volume":"182","author":"Weinstock H","year":"2000","journal-title":"J Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00126334-200102010-00006","article-title":"Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid","volume":"26","author":"Briones C","year":"2000","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00126334-200103010-00010","article-title":"Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study","volume":"26","author":"Duwe S","year":"2001","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/bmj.322.7294.1087","article-title":"Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom","volume":"322","year":"2001","journal-title":"BMJ","ISSN":"https:\/\/id.crossref.org\/issn\/0959-8138","issn-type":"print"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00002030-200203290-00017","article-title":"Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment","volume":"16","author":"Harzic M","year":"2002","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jama.288.2.181","article-title":"Time trends in primary HIV-1 drug resistance among recently infected persons","volume":"288","author":"Grant RM","year":"2002","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00126334-200404150-00008","article-title":"High-risk behavior and potential transmission of drug-resistant HIV among injection drug users","volume":"35","author":"Sethi AK","year":"2004","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"}],"container-title":["Cadernos de Sa\u00fade P\u00fablica"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/csp\/v22n4\/02.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T12:02:16Z","timestamp":1495713736000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-311X2006000400002&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":150,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0102-311X2006000400002"],"URL":"https:\/\/doi.org\/10.1590\/s0102-311x2006000400002","relation":{},"ISSN":["0102-311X"],"issn-type":[{"value":"0102-311X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}